Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-25-000220
Filing Date
2025-01-06
Accepted
2025-01-06 19:30:43
Documents
1
Period of Report
2025-01-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 6292
  Complete submission text file 0001562180-25-000220.txt   7791
Mailing Address C/O APPLIED THERAPEUTICS, INC. 340 MADISON AVENUE, 19TH FLOOR NEW YORK NY 10173
Business Address
Vignola Mark J. (Reporting) CIK: 0001775429 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39926 | Film No.: 25513062

Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Issuer) CIK: 0001831363 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)